Leaflet ROXIHEFA 300mg film-coated tablets


Indicated for: bacterial infections

Substance: roxithromycin (macrolide antibiotic)

ATC: J01FA06 (Antiinfectives for systemic use | Macrolides, lincosamides and streptogramins)

Roxithromycin is a macrolide antibiotic used in the treatment of bacterial infections of the respiratory tract, skin, and soft tissues. It works by inhibiting bacterial protein synthesis, thereby blocking the growth and multiplication of susceptible bacteria.

Roxithromycin is administered orally, usually in tablet form, and is effective against a wide range of bacteria, including Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae. It is commonly used to treat bronchitis, pharyngitis, tonsillitis, and skin infections.

Common side effects include nausea, diarrhea, abdominal pain, and headache. In rare cases, severe allergic reactions or liver disorders may occur. It is important to take it as directed by a physician to prevent the development of bacterial resistance.

Roxithromycin is an effective and well-tolerated option for the treatment of bacterial infections, helping patients recover quickly.

General data about ROXIHEFA 300mg

  • Substance: roxithromycin
  • Date of last drug list: 01-07-2013
  • Commercial code: W42346001
  • Concentration: 300mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 10
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for roxithromycin

Concentrations available for roxithromycin

  • 150mg
  • 300mg
  • 50mg